Advertisement

Viral Subversion of the Immune System

  • Laurent Gillet
  • Alain Vanderplasschen
Conference paper
  • 1k Downloads

Abstract

The continuous interactions between host and viruses during their co-evolution have shaped not only the immune system but also the countermeasures used by viruses. Studies in the last decade have described the diverse arrays of pathways and molecular targets that are used by viruses to elude immune detection or destruction, or both. These include targeting of pathways for major histocompatibility complex class I and class II antigen presentation, natural killer cell recognition, apoptosis, cytokine signalling, and complement activation. This paper provides an overview of the viral immune-evasion mechanisms described to date. It highlights the contribution of this field to our understanding of the immune system, and the importance of understanding this aspect of the biology of viral infection to develop efficacious and safe vaccines.

Keywords

Major Histocompatibility Complex Natural Killer Cell Major Histocompatibility Complex Class Human Cytomegalovirus Transporter Associate With Antigen Processing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahn, K., Gruhler, A., Galocha, B., Jones, T.R., Wiertz, E.J.H.J., Ploegh, H.L., Peterson, P.A., Yang, Y. & Fruh, K. 1997. The EER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity, 6: 613–621.CrossRefPubMedGoogle Scholar
  2. Ahn, K., Meyer, T.H., Uebel, S., Sempe, P., Djaballah, H., Yang, Y., Peterson, P.A., Fruh, K. & Tampe, R. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47. EMBO Journal, 15: 3247–3255.PubMedGoogle Scholar
  3. Ahn, K.S., Agulo, A., Ghazal, P., Peterson, P.A., Yang, Y. & Fruh, K. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proceedings of the National Academy of Sciences, USA, 93: 10990–10995.CrossRefGoogle Scholar
  4. Albini, A., Ferrini, S., Benelli, R., Sforzini, S., Giunciuglio, D., Aluigi, M.G., Proudfoot, A.E.I., Alouani, S., Wells, T.N.C., Mariani, G., Rabin, R.L., Farber, J.M. & Noonan, D.M. 1998. HIV-1 Tat protein mimicry of chemokines. Proceedings of the National Academy of Sciences, USA, 95: 13153–13158.CrossRefGoogle Scholar
  5. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nature Reviews Immunology, 3: 36–50.CrossRefPubMedGoogle Scholar
  6. Alcami, A. & Smith, G.L. 1992. A soluble receptor for interleukin-1-beta encoded by vaccinia virus — a novel mechanism of virus modulation of the host response to infection. Cell, 71: 153–167.CrossRefPubMedGoogle Scholar
  7. Alcami, A. & Smith, G.L. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma-interferon receptors with novel broad species specificity. Journal of Virology, 69: 4633–4639.PubMedGoogle Scholar
  8. Alcami, A. & Smith, G.L. 1996. A mechanism for the inhibition of fever by a virus. Proceedings of the National Academy of Sciences, USA, 93: 11029–11034.CrossRefGoogle Scholar
  9. Alcami, A., Symons, J.A., Collins, P.D., Williams, T.J. & Smith, G.L. 1998. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. Journal of Immunology, 160: 624–633.Google Scholar
  10. Alfonso, C.L., Neilan, J.G., Kutish, G.H. & Rock, D.L. 1996. An African swine fever virus Bcl-2 homolog, 5-HL, suppresses apoptotic cell death. Journal of Virology, 70: 4858–4863.Google Scholar
  11. Andresson, T., Sparkowski, J., Goldstein, D.J., & Schlegel, R. 1995. Vacuolar H+ATPase mutants transform cells and define a binding site for the papillomavirus E5 on oncoprotein. Journal of Biological Chemistry, 270: 6830–6837.PubMedGoogle Scholar
  12. Aoki, Y., Jaffe, E.S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P.S. & Tosato, G. 1999. Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6. Blood, 93: 4034–4043.PubMedGoogle Scholar
  13. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science, 296: 1323–1326.CrossRefPubMedGoogle Scholar
  14. Arvanitakis, L., Geras Raaka, E., Varma, A., Gershengorn, M.C. & Cesarman, F. 1997. Human herpesvirus KSHV, encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature, 385: 347–350.CrossRefPubMedGoogle Scholar
  15. Atalay, R., Zimmermann, Z., Wagner, M., Borst, E., Benz, C., Messerle, M. & Hengel, H. 2002. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc gamma receptor homologs. Journal of Virology, 76: 8596–8608.CrossRefPubMedGoogle Scholar
  16. Beck, S. & Barrell, B.G. 1988. Human cytomegalo-virus encodes a glycoprotein homologous to MHC class-I antigens. Nature, 331: 269–272.CrossRefPubMedGoogle Scholar
  17. Benedict, C.A., Butrovich, K.D., Lurain, N.S., Corbeil, J., Rooney, I., Schneider, P., Tschopp, J. & Ware, C.F. 1999. Cutting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. Journal of Immunology, 162: 6967–6970.Google Scholar
  18. Benedict, C.A., Norris, P.S. & Ware, C.F. 2002. To kill or be killed: viral evasion of apoptosis. Nature Immunology, 3: 1013–1018.CrossRefPubMedGoogle Scholar
  19. Benedict, C.A., Norris, P.S., Prigozy, T.I., Bodmer, J.L., Mahr, J.A., Garnett, C.T., Martinon, F., Tschopp, J., Gooding, L.R. & Ware, C.F. 2001. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and-2. Journal of Biological Chemistry, 276: 3270–3278.CrossRefPubMedGoogle Scholar
  20. Bennett, E.M., Bennink, J.R., Yewdell, J.W. & Brodsky, F.M. 1999. Cutting edge: Adenovirus E19 has two mechanisms for affecting class-I MHC expression. Journal of Immunology, 162: 5049–5052.Google Scholar
  21. Bertin, J., Armstrong, R.C., Ottilie, S., Martin, D.A., Wang, Y., Banks, S., Wang, G.H., Senkevich, T.G., Alnemri, E.S., Moss, B., Lenardo, M.J., Tomaselli, K.J. & Cohen, J.I.1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proceedings of the National Academy of Sciences, USA, 94: 1172–1176.CrossRefGoogle Scholar
  22. Bertin, J., Mendrysa, S.M., LaCount, D.J., Gaur, S., Krebs, J.F., Armstrong, R.C., Tomaselli, K.J. & Friesen, P.D. 1996. Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. Journal of Virology, 70: 6251–6259.PubMedGoogle Scholar
  23. Bodaghi, B., Jones, T.R., Zipeto, D., Vita, C., Sun, L., Laurent, L., Arenzan-Seisdedos, F., Virelizier, J.L. & Michelson, S. 1998. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells. Journal of Experimental Medicine, 188: 855–866.CrossRefPubMedGoogle Scholar
  24. Boname, J.M. & Stevenson, P.G. 2001. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity, 15: 627–636.CrossRefPubMedGoogle Scholar
  25. Born, T.L., Morrison, L.A., Esteban, D.J., Van den Bos, T., Thebeau, L.G., Chen, N.H., Spriggs, M.K., Sims, J.E. & Buller, R.M.L. 2000. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. Journal of Immunology, 164: 3246–3254.Google Scholar
  26. Boshoff, C., Endo, Y., Collins, P.D., Takeuchi, Y., Reeves, J.D., Schweickart, V.L., Siani, M.A., Sasaki, T., Williams, T.J., Gray, P.W., Moore, P.S., Chang, Y. & Weiss, R.A. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science, 278: 290–294.CrossRefPubMedGoogle Scholar
  27. Bryant, N.A., Davis-Poynter, N., Van der Plasschen, A. & Alcami, A. 2003. Glycoprotein G isoforms from some alpha herpesviruses function as broad-spectrum chemokine binding proteins. EMBO Journal, 22: 833–846.CrossRefPubMedGoogle Scholar
  28. Burgert, H.G. & Kvist, S. 1987. The E3/19K protein of adenovirus type-2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO Journal, 6: 2019–2026.PubMedGoogle Scholar
  29. Chacon, M.R., Almazan, F., Nogal, M.L., Vinuela, E. & Rodriguez, J.F. 1995. The African swine fever virus IAP homolog is a late structural polypeptide. Virology, 214: 670–674.PubMedGoogle Scholar
  30. Chehimi, J., Bandyopodhyay, S., Prakash, K., Perussia, B., Hassan, N.F., Kawashima, H., Campbell, D., Kornbuth, J. & Starr, S.E. 1991. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates. Journal of Virology, 65: 1812–1822.PubMedGoogle Scholar
  31. Cho, Y.S., Kang, J.W., Cho, M., Cho, C.W., Lee, S., Choe, Y.K., Kim, Y., Choi, I., Park, S.N., Kim. S., Dinarello, C.A. & Yoon, D.Y. 2001. Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Letters, 501: 139–145.CrossRefPubMedGoogle Scholar
  32. Clem, R.J. 2001. Baculoviruses and apoptosis: the good, the bad, and the ugly. Cell Death and Differentiation, 8: 137–143.CrossRefPubMedGoogle Scholar
  33. Clem, R.J., Fechheimer, M. & Miller, L.K. 1991. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science, 254: 1388–1390.PubMedGoogle Scholar
  34. Cohen, G.B., Gandhi, R.T., Davis, D.M., Mandelboim, O., Chen, B.K., Strominger, J.L. & Baltimore, D. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity, 10: 661–671.CrossRefPubMedGoogle Scholar
  35. Colamonici, O.R., Domanski, P., Sweitzer, S.M., Larner, A. & Buller, R.M.L. 1995. Vaccinia virus B18R gene encodes a type-I interferon-binding protein that blocks interferon-alpha transmembrane signaling. Journal of Biological Chemistry, 270: 15974–15978.PubMedGoogle Scholar
  36. Coscoy, L. & Ganem, D. 2001. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. Journal of Clinical Investigation, 107: 1599–1606.PubMedCrossRefGoogle Scholar
  37. Coscoy, L., Sanchez, D.J. & Ganem, D. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. Journal of Cell Biology, 155: 1265–1273.CrossRefPubMedGoogle Scholar
  38. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., Hsu, M.L. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity, 7: 273–282.CrossRefPubMedGoogle Scholar
  39. Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. & Chalupny, N.J. 2001. ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate KN cytotoxicity through the NKG2D receptor. Immunity, 14: 123–133.CrossRefPubMedGoogle Scholar
  40. Cox, J.H., Bennink, J.R. & Yewdell, J.W. 1991. Retention of adenovirus-E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. Journal of Experimental Medicine, 174: 1629–1637.CrossRefPubMedGoogle Scholar
  41. Cretney, E., Degli-Esposti, M.A., Densley, E.H., Farrell, H.E., Davis-Poynter, N.J. & Smyth, M.J. 1999. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. Journal of Experimental Medicine, 190: 435–444.CrossRefPubMedGoogle Scholar
  42. Crook, N.E., Clem, R.J. & Miller, L.K. 1993. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. Journal of Virology, 67: 2168–2174.PubMedGoogle Scholar
  43. Crotta, S., Stilla, A., Wack, A., D’Andrea, A., Nuti, S., D’Oro, U., Mosca, M., Filliponi, F., Brunnetto, R.M., Bonino, F., Abrignani, S. & Valiante, N.M. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C envelope protein. Journal of Experimental Medicine, 195: 35–41.PubMedGoogle Scholar
  44. Davis-Poynter, N.J., Lynch, D.M., Vally, H., Shellam, G.R., Rawlinson, W.D., Barrell, B.G. & Farrell, H.E. 1997. Identification and characterization of a G-protein-coupled receptor homolog encoded by murine cytomegalovirus. Journal of Virology, 71: 1521–1529.PubMedGoogle Scholar
  45. Dbaibo, G.S. & Hannun, Y.A. 1998. Cytokine response modifier A (CrmA): A strategically deployed viral weapon. Clinical Immunology and Immunopathology, 86: 134–140.CrossRefPubMedGoogle Scholar
  46. Deane, D., McInnes, C.J., Percival, A., Wood, A., Thomson, J., Lear, A., Gilray, J., Fleming, S., Mercer, A. & Haig, D. 2000. Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. Journal of Virology, 74: 1313–1320.CrossRefPubMedGoogle Scholar
  47. Derfuss, T., Fickenscher, H., Kraft, M.S., Henning, G., Lengenfelder, D., Fleckenstein, B. & Meinl, E. 1998. Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: Stabilization of mitochondria and inhibition of caspase-3-like activity. Journal of Virology, 72: 5897–5904.PubMedGoogle Scholar
  48. Dobbelstein, M. & Shenk, T. 1996. Protection against apoptosis by the vaccinia virus SPI-2 (B13R)gene product. Journal of Virology, 70: 6479–6485.PubMedGoogle Scholar
  49. Farrell, H.E., Vally, H., Lynch, D.M., Fleming, P., Shellam, G.R., Scalzo, A.A. & Davis Poynter, N.J. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature, 386: 510–514.CrossRefPubMedGoogle Scholar
  50. Favoreel, H.W., Nauwynck, H.J., Halewyck, H.M., Van Oostveldt, P., Mettenleiter, T.C. & Pensaert, M.B. 1999. Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. Journal of General Virology, 80: 1283–1291.PubMedGoogle Scholar
  51. Favoreel, H.W., Nauwynck, H.J., Van Oostveldt, P., Mettenleiter, T.C. & Pensaert, M.B. 1997. Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. Journal of Virology, 71: 8254–8261.PubMedGoogle Scholar
  52. Favoreel, H.W., Van de Walle, G.R., Nauwynck, H.J. & Pensaert, M.B. 2003. Virus complement evasion strategies. Journal of General Virology, 84: 1–15.PubMedGoogle Scholar
  53. Fleming, P., Davis-Poynter, N., Degli-Esposti, M., Densley, E., Papadimitriou, J., Shellam, G. & Farrell, H. 1999. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. Journal of Virology, 73: 6800–6809.PubMedGoogle Scholar
  54. Fleming, S.B., McCaughan, C.A., Andrews, A.E., Nash, A.D. & Mercer, A.A. 1997. A homolog of interleukin-10 is encoded by the poxvirus orf virus. Journal of Virology, 71: 4857–4861.PubMedGoogle Scholar
  55. Fletcher, J.M., Prentice, H.G. & Grundy, J.E. 1998. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. Journal of Immunology, 161: 2365–2374.Google Scholar
  56. Fodor, W.L., Rollins, S.A., Biancocaron, S., Rother, R.P., Guilmette, E.R., Burton, W.V., Albrecht, J.C., Fleckenstein, B. & Squinto, S.P. 1995. The complement control protein homolog of herpesvirus Saimiri regulates serum complement by inhibiting C3 convertase activity. Journal of Virology, 69: 3889–3892.PubMedGoogle Scholar
  57. Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Seidel, C.A. & Cines, D.B. 1984. Glycoprotein-C of herpes simplex virus-1 acts as a receptor for the C3B complement on infected cells. Nature, 309: 633–635.CrossRefPubMedGoogle Scholar
  58. Galocha, B., Hill, A., Barnett, B.C., Dolan, A., Raimondi, A., Cook, R.F., Brunner, J., McGeoch, D.J. & Ploegh, H.L. 1997. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatability complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. Journal of Experimental Medicine, 185: 1565–1572.CrossRefPubMedGoogle Scholar
  59. Gardner, J.D., Tscharke, D.C., Reading, P.C. & Smith, G.L. 2002. Vaccinia virus semaphorin A39R is a 50–55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. Journal of General Virology, 82: 2083–2093.Google Scholar
  60. Gewurz, B.E., Wang, E.W., Tortorella, D., Schiust, D.J. & Ploegh, H.L. 2001. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. Journal of Virology, 75: 5197–5204.CrossRefPubMedGoogle Scholar
  61. Gilbert, M.J., Riddell, S.R., Li, C.R. & Greenberg, P.D. 1993. Journal of Virology, 67: 3461–3469.PubMedGoogle Scholar
  62. Glykofrydes, D., Niphuis, H., Kuhn, E.M., Rosenwirth, B., Heeney, J.L., Bruder, J., Niedobitek, G., Muller-Fleckstein, I., Fleckstein, B. & Ensser, A. 2000. Herpesvirus Saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. Journal of Virology, 74: 11919–11927.CrossRefPubMedGoogle Scholar
  63. Goldmacher, V.S., Bartle, L.M., Skaletskaya, A., Dionne, C.A., Kedersha, E.S., Vater, C.A., Han, J.W., Lutz, R.J., Watanabe, S., McFarland, E.D.C., Kieff, E.D., Mocarski, E.S. & Chittenden, T. 1999. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proceedings of the National Academy of Sciences, USA, 96: 12536–12541.CrossRefGoogle Scholar
  64. Gooding, L.R., Elmore, L.W., Tollefson, A.E., Brady, H.A. & Wold, W.S.M. 1988. A 14,700 mw protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell, 53: 341–346.CrossRefPubMedGoogle Scholar
  65. Gooding, L.R., Ranheim, T.S., Tollefson, A.E., Aquino, L., Duerksen-Hughes, P., Horton, T.M. & Wold, W.S.M. 1991. The 10,400-Dalton and 14,500-Dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mousecell lines against lysis by tumor-necrosis-factor. Journal of Virology, 65: 4114–4123.PubMedGoogle Scholar
  66. Graham, K.A., Lalani, A.S., Macen, J.L., Ness, T.L., Barry, M., Liu, L.Y., Lucas, A., Clark Lewis, A., Moyer, R.W. & McFadden, G. 1997. The T1/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology, 229: 12–24.CrossRefPubMedGoogle Scholar
  67. Hegde, N.R., Chevalier, M.S., Johnson, D.C. 2003. Viral inhibition of MHC class II antigen presentation. Trends in Immunology, 24: 278–285.CrossRefPubMedGoogle Scholar
  68. Hegde, N.R., Tomasin R.A., Wisner, T.W., Dunn, C., Boname, J.M., Lewinsohn, D.M. & Johnson, D.C. 2002. Inhibition of HLA-DR assembly, transport and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatability complex class II antigen presentation. Journal of Virology, 76: 10929–10941.CrossRefPubMedGoogle Scholar
  69. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G. & Rickinson, A. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homolog of BCL-2, protects human B-cells from programmed cell-death. Proceedings of the National Academy of Sciences, USA, 90: 8479–8483.Google Scholar
  70. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kiefe, E. & Rickinson, A. 1991. Induction of BCL-2 expression by Epstein-Barr-virus latent membrane protein-1 protects infected B-cells from programmed cell-death. Cell, 65: 1107–1115.CrossRefPubMedGoogle Scholar
  71. Hengel, H., Flohr, T., Hammerling, G.J., Koszinowski, U.H. & Momburg, F. 1996. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. Journal of General Virology, 77: 2287–2296.PubMedCrossRefGoogle Scholar
  72. Hengel, H., Koopmann, J.O., Flohr, T., Muranyi, W., Goulmy, E., Hammerling, G.J., Koszinowski, U.H. & Momburg, F. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity, 6: 623–632.CrossRefPubMedGoogle Scholar
  73. Henry, H., Thomas, A., Shen, Y. & White, E. 2002. Regulation of the mitrochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death. Oncogene, 21: 748–760.CrossRefPubMedGoogle Scholar
  74. Hewitt, E.W., Duncan, L., Mufti, D., Baker, J., Stevenson, P.G. & Lehner, P.J. 2002. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-depenedent degradation. EMBO Journal, 21: 2418–2429.CrossRefPubMedGoogle Scholar
  75. Hinkley, S., Hill, A.B. & Srikumaran, S. 1998. Bovine herpesvirus-1 infection affects peptide transport activity in bovine cells. Virus Research, 53: 91–96.CrossRefPubMedGoogle Scholar
  76. Hirsch, R.L., Griffin, D.E. & Winkelstein, J.A. 1981. Host modification of Sindbis virus sialic-acid content influences alternative complement pathway activation and virus clearance. Journal of Immunology, 127: 1740–1743.Google Scholar
  77. Howard, J., Justus, D.E., Totmenin, A.V., Shchelkunov, S. & Kotwal, G.J. 1998. Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat. Journal of Leukocyte Biology, 64: 68–71.PubMedGoogle Scholar
  78. Hsu, D.H., Malefyt, R.D., Fiorentino, D.F., Dang, M.N., Vieira, P., DeVries, J., Spits, H., Mosmann, T.R. & Moore, K.W. 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science, 250: 830–832.PubMedGoogle Scholar
  79. Hu, F.Q., Smith, C.A. & Pickup, D.J. 1994. Cowpox virus contains 2 copies of an early gene encoding a soluble secreted form of the Type-II TNF receptor. Virology, 204: 343–356.CrossRefPubMedGoogle Scholar
  80. Huemer, H.P., Larcher, C., Littel van den Hurk, S.V. & Babiuk, L.A. 1993. Species selection interaction of alphaherpesvirinae with the unspecific immune-system of the host. Archives of Virology, 130: 353–564.CrossRefPubMedGoogle Scholar
  81. Inngjerdingen, M., Damaj, B. & Maghazachi, A.A. 2001. Expression and regulation of chemokine receptors in human natural killer cells. Blood, 97: 367–375.CrossRefPubMedGoogle Scholar
  82. Ishido, S., Choi, J.K., Lee, B.S., Wang, C.Y., DeMaria, M., Johnson, R.P., Cohen, G.B. & Jung J.U. 2000. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi’s sarcoma-associated herpesvirus K5 protein. Immunity, 13: 365–374.CrossRefPubMedGoogle Scholar
  83. Ishido, S., Wang, C.Y., Lee, B.S., Cohen, G.B. & Jung, J.U. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins. Journal of Virology, 74: 5300–5309.CrossRefPubMedGoogle Scholar
  84. Jefferies, W.A. & Burgert, H.G. 1990. E3/19K from adenovirus-2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class-I proteins. Journal of Experimental Medicine, 172: 1653–1664.CrossRefPubMedGoogle Scholar
  85. Jerome, K.R., Fox, R., Chen, Z., Sears, A.E., Lee, H.Y. & Corey, L. 1999. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. Journal of Virology, 73: 8950–8957.PubMedGoogle Scholar
  86. Johnson, J.M., Nicot, C., Fullen, J., Ciminal, V., Casareto, L., Mulloy, J.C., Jacobson, S. & Franchini, G. 2001. Free major histocompatability complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. Journal of Virology, 75: 6086–6094.PubMedGoogle Scholar
  87. Jones, T.R., Wiertz, E.J.H.J., Sun, L., Nelson, J.A. & Ploegh, H.L. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class-I heavy chains. Proceedings of the National Academy of Sciences, USA, 93: 11327–11333.Google Scholar
  88. Kavanagh, D.G., Gold, M.C., Wagner, M., Koszinowski, U.H. & Hill, A.B. 2001. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. Journal of Experimental Medicine, 194: 967–977.CrossRefPubMedGoogle Scholar
  89. Kavanagh, D.G., Koszinowski, U.H. & Hill, A.B. 2001. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class-I MHC at the cell surface and in a pre-golgi compartment. Journal of Immunology, 167: 3894–3902.Google Scholar
  90. Kawanishi, M. 1997. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. Journal of Virology, 71: 3319–3322.PubMedGoogle Scholar
  91. Kawanishi, M. 1997. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Virology, 228: 244–250.CrossRefPubMedGoogle Scholar
  92. Kerkau, T., Bacik, I., Bennink, J.R., Yewdell, J.W., Hunig, T., Schimpl, A. & Schubert, U. 1997. The human immunodeficiency virus type 1 (HIV-1) vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. Journal of Experimental Medicine, 185: 1295–1305.CrossRefPubMedGoogle Scholar
  93. Kledal, T.N., Rosenkilde, M.M., Coulin, F., Simmons, G., Johnsen, A.H., Alouani, S., Power, C.A., Luttichau, H.R., Gerstoft, J., Clapham, P.R., Clark-Lewis, I., Wells, T.N.C. & Schwartz, T.W. 1997. A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science, 277: 1656–1659.CrossRefPubMedGoogle Scholar
  94. Kleijnen, M.F., Huppa, J.B., Lucin, P., Mukherjee, S., Farrell, H., Campbell, A.E., Koszinowski, U.H., Hill, A.B. & Ploegh, H.L. 1997. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO Journal, 16: 685–694.CrossRefPubMedGoogle Scholar
  95. Kloover, J.S., Grauls, G.E.L.M., Blok, M.J., Vink, C. & Bruggeman, C.A. 2002. A rat cytomegalovirus strain with a disruption of the r144 MHC class I-like gene is attenuated in the acute phase of infection in neonatal rats. Archives of Virology, 147: 813–824.CrossRefPubMedGoogle Scholar
  96. Kostavasili, I., Sahu, A., Friedman, H.M., Eisenberg, R.J., Cohen, G.H. & Lambris, J.D. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. Journal of Immunology, 158: 1763–1771.Google Scholar
  97. Kotenko, S.V., Saccani, S., Izotova, L.S., Mirochinitchenko, O.V. & Pestka, S. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmcIL-10). Proceedings of the National Academy of Sciences, USA, 97: 1695–1700.CrossRefGoogle Scholar
  98. Kotwal, G.J., Isaacs, S.N., McKenzie, R., Frank, M.M. & Moss, B. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science, 250: 827–830.PubMedGoogle Scholar
  99. Krathwohl, M.D., Hromas, R., Brown, D.R., Broxmeyer, H.E. & Fife, K.H. 1997. Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proceedings of the National Academy of Sciences, USA, 94: 9875–9880.CrossRefGoogle Scholar
  100. Krmpotic, A., Busch, D.H., Bubic, I., Gebhardt, F., Hengel, H., Hasan, M., Scalzo, A.A., Koszinowski, U.H. & Jonjic, S. 2002. MCMV glycoprotein gb40 confers virus resistance to CD8(+)T cells and NK cells in vivo. Nature Immunolog, 3: 529–535.Google Scholar
  101. Kubin, M., Cassiano, L., Chalupny, J., Chin, W., Cosman, D, Fanslow, W., Mulberg, J., Rousseau, A.M., Ulrich, D. & Armitage, R. 2001. ULBP1, 2,3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. European Journal of Immunology, 31: 1428–1437.CrossRefPubMedGoogle Scholar
  102. Kubota, A., Kubota, S., Farrell, H.E., Davis Poynter, N. & Takei, F. 1999. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cellular Immunology, 191: 145–151.CrossRefPubMedGoogle Scholar
  103. Lane, D.P. & Crawford, L.V. 1979. T-antigen is bound to a host protein in SV-40-transformed cells. Nature, 278: 261–263.CrossRefPubMedGoogle Scholar
  104. Le Gall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L.X., Benarous, R., Heard, J.M. & Schwartz, O. 1998. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity, 8: 483–495.PubMedGoogle Scholar
  105. Lee, H.J., Essani, K. & Smith, G.L. 2001. The genome sequence of Yaba-like disease virus. a yatapoxvirus. Virology, 281: 170–92.CrossRefPubMedGoogle Scholar
  106. Lee, S.J., Cho, Y.S., Cho, M.C., Shim, J.H., Lee, K.A., Ko, Y.K., Park, S.N., Hoshino, T., Kim, S., Dinarello, C.A. & Yoon, D.Y. 2001. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells. Journal of Immunology, 167: 497–504.Google Scholar
  107. Lehner, P.J., Karttunen, J.T., Wilkinson, G.W.G. & Cresswell, P. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proceedings of the National Academy of Sciences, USA, 94: 6904–6909.CrossRefGoogle Scholar
  108. Leonard, G.T. & Sen, G.C. 1996. Effects of adenovirus E1A protein on interferon signaling. Virology, 224: 25–33.CrossRefPubMedGoogle Scholar
  109. Leong, C.C., Chapman, T.L., Bjorkman, P.J., Formankova, D., Mocarski, E.S., Phillips, J.H. & Lanier, L.L. 1998. Modulation of the natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog. Journal of Experimental Medicine, 187: 1681–1687. [See also correction: ibid., 188: 615.]CrossRefPubMedGoogle Scholar
  110. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steiger-Waldmullen, P.M., Klein, G., Kurill, M.G. & Masucci, M.G. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature, 375: 685–688.CrossRefPubMedGoogle Scholar
  111. Lewandowski, G.A., Lo, D. & Bloom, F.E. 1993. Interference with major histo-compatibility complex class II restricted antigen presentation in the brain by herpes-simplex virus type 1 — A possible mechanism of evasion of the immune response. Proceedings of the National Academy of Sciences, USA, 90: 2005–2009.Google Scholar
  112. Li, Y.G., Kang, J. & Horowitz, M.S. 1998. Interaction of an adenovirus E3 14.7-kiloDalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Molecular and Cellular Biology, 18: 1601–1610.PubMedGoogle Scholar
  113. Lilley, B.N., Ploegh, H.L. & Tirabassi, R.S. 2001. Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. Journal of Virology, 75: 11218–11221.PubMedGoogle Scholar
  114. Linzer, D.I.H. & Levine, A.J. 1979. Characterization of a 54 kDalton cellular SV40 tumor-antigen present in SV40-transformed cells and uninfected embryonal carcinoma-cells. Cell, 17: 43–52.CrossRefPubMedGoogle Scholar
  115. Loparev, V.N., Parsons, J.M., Knight, J.C., Panus, J.F., Ray, C.A., Buller, R.H.L., Pickup, D.J. & Esposito, J.J. 1998. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proceedings of the National Academy of Sciences, USA, 95: 3786–3791.CrossRefGoogle Scholar
  116. Lopez-Botet, M., Llano, M. & Ortega, M. 2001. Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunological Reviews, 181: 193–202.CrossRefPubMedGoogle Scholar
  117. Luttichau, H.R., Stine, J., Boesen, T.P., Johnsen, A.H., Chantry, D., Gerstoft, J. & Schwartz, T.W. 2000. A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. Journal of Experimental Medicine, 191: 171–180.CrossRefPubMedGoogle Scholar
  118. Lybarger, L., Wang, X.L., Harris, M.R., Virgin, H.W. & Hansen, T.H. 2003. Virus subversion of the MHC class I peptide-loading complex. Immunity, 18: 121–130.CrossRefPubMedGoogle Scholar
  119. Macen, J.L., Graham, K.A., Lee, S.F., Schreiber, M., Boshkov, L.K. & McFadden, G. 1996. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes required to prevent virus-induced apoptosis in infected rabbit lymphocytes. Virology, 218: 232–237.CrossRefPubMedGoogle Scholar
  120. Machold, R.P., Wiertz, E.J.H.J., Jones, T.R. & Ploegh, H.L. 1997. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. Journal of Experimental Medicine, 185: 363–366.CrossRefPubMedGoogle Scholar
  121. Maeda, K., Hayashi, S., Tanioka, Y., Matsumoto, Y. & Otsuka, H. 2002. Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC). Virus Research, 84: 79–87.CrossRefPubMedGoogle Scholar
  122. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T.I., Bushkin, Y., Davis, D.M., Strominger, J.L., Yewdell, J.W. & Porgador, A. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature, 409: 1055–1060.CrossRefPubMedGoogle Scholar
  123. Marshall, W.L., Yim, C., Gustafson, E., Graf, T., Sage, D.R., Hanify, K., Williams, L., Fingeroth, J. & Finberg, R.W. 1999. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. Journal of Virology, 73: 5181–5185.PubMedGoogle Scholar
  124. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H.G., Ziche, M., Lanz, C., Buttner, M., Rziha, H.J. & Dehio, C. 1999. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO Journal, 18: 363–374.CrossRefPubMedGoogle Scholar
  125. Miller, D.M., Rahill, B.M., Lairmore, M.D., Durbin, J.E., Waldman, W.J. & Sedmark, D.D. 1998. Human cytomegalovirus inhibits major histocompatability complex class II expression by disruption of the Jak/Stat pathway. Journal of Experimental Medicine, 187: 675–683.CrossRefPubMedGoogle Scholar
  126. Miller, D.M., Zhang, Y.X., Rahill, B.M., Waldman, W.J. & Sedmak, D.D. 1999. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. Journal of Immunology, 162: 6107–6113.Google Scholar
  127. Milne, R.S.B., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A. & Gompels, U.A. 2000. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokin receptor. Journal of Immunology, 164: 2396–2404.Google Scholar
  128. Mold, C., Bradt, B.M., Nemerow, G.R. & Cooper, N.R. 1988. Epstein-Barr virus regulates activation and processing of the 3RD component of complement. Journal of Experimental Medicine, 168: 949–969.CrossRefPubMedGoogle Scholar
  129. Moore, K.W., Viera, P., Fiorentino, D.F., Trounstine, M.L., Khan, T.A. & Mosmann, T.R. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science, 248: 1230–1234.PubMedGoogle Scholar
  130. Mossman, K., Nation, P., Macen, J., Garbutt, M., Lucas, A. & McFadden, G. 1996. Myxoma virus M-T7. a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology, 215: 17–30.CrossRefPubMedGoogle Scholar
  131. Murphy, P.M. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nature Immunology, 2: 116–122.CrossRefPubMedGoogle Scholar
  132. Nava, V.E., Cheng, E.H.Y., Veliuona, M., Zhou, S.F., Clem, R.J., Mayer, M.L. & Hardwick, J.M. 1997. Herpesvirus Saimiri encodes a functional homolog of the human bcl-2 oncogene. Journal of Virology, 71: 4118–4122.PubMedGoogle Scholar
  133. Neumann, J., Eis-Hubinger, A.M. & Koch, N. 2003. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. Journal of Immunology, 171: 3075–3083.Google Scholar
  134. Ng, A., Tscharke, D.C., Reading, P.C. & Smith, G.L. 2001. The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. Journal of General Virology, 82: 2095–2105.PubMedGoogle Scholar
  135. Nogal, M.L., de Buitrago, G.G., Rodriguez, C., Cubelos, B., Carrascosa, A.L., Salas, M.L. & Revilla, Y. 2001. African swine fever virus IAP homolog inhibits caspase activation and promotes cell survival in mammalian cells. Journal of Virology, 75: 2535–2543.CrossRefPubMedGoogle Scholar
  136. Ogata, M. & Shigeta, S. 1979. Appearance of immunoglobulin-GFC receptor in cultured human cells infected with varicella-zoster virus. Infection and Immunity, 26: 770–774.PubMedGoogle Scholar
  137. Oleszak, E.L., Perlman, S., Parr, R., Collisson, E.W. & Leibowitz, J.L. 1993. Molecular mimicry between S peplomer proteins of coronaviruses (MHV, BCV, TGEV and IBV) and Fc receptor. Advances in Experimental Medicine and Biology, 342: 183–188.PubMedGoogle Scholar
  138. Orange, J.S., Fassett, M.S., Koopman, L.A., Boyson, J.E. & Strominger, J.L. 2002. Viral evasion of natural killer cells. Nature Immunology, 3: 1006–1012.CrossRefPubMedGoogle Scholar
  139. Pan, H. & Griep, A.E. 1995. Temporally distinct patterns of P53-dependent and P53-independent apoptosis during mouse lens development. Genes and Development, 9: 2157–2169.PubMedGoogle Scholar
  140. Panus, J.F., Smith, C.A., Ray, C.A., Smith, T.D., Patel, D.D. & Pickup, D.J. 2002. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue. Proceedings of the National Academy of Sciences, USA, 99: 8348–8353.CrossRefGoogle Scholar
  141. Parcells, M.S., Lin, S.F., Dienglewicz, R.L., Majerciak, V., Robinson, D.R., Chen, H.C., Wu, Z.N., Dubyak, G.R., Brunovskis, P., Hunt, H.D., Lee, L.F. & Kung, H.J. 2001. Marek’s disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. Journal of Virology, 75: 5159–5173.CrossRefPubMedGoogle Scholar
  142. Park, B., Oh, H., Lee, S., Song, Y.S., Shin, J., Sung, Y.C., Hwang, S.Y. & Ahn, K. 2002. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. Journal of Immunology, 168: 3464–3469.Google Scholar
  143. Parry, C.M., Simas, J.P., Smith, V.P., Stewart, C.A., Minson, A.C., Efstathoiu, S. & Alcami, A. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. Journal of Experimental Medicine, 191: 573–578.CrossRefPubMedGoogle Scholar
  144. Penfold, M.E.T., Dairaghi, D.J., Duke, G.M., Saederup, N., Mocarski, E.S., Kemble, G.W. & Schall, T.J. 1999. Cytomegalovirus encodes a potent alpha chemokine. Proceedings of the National Academy of Sciences, USA, 96: 9839–9844.CrossRefGoogle Scholar
  145. Poggi, A., Carosio, R., Spaggiari, G.M., Fortis, C., Tambussi, G., Dell’Antonio, G., Dal Cin, E., Rubartelli, A. & Zocchi, M.R. 2002. NK cell inactivation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: Inhibition by HIV-1 Tat C-terminal domain. Journal of Immunology, 168: 95–101.Google Scholar
  146. Rakoff-Nahoum, S., Chen, H.C., Kraus, T., George, I., Oei, E., Tyorkin, M., Salik, E., Beuria, P. & Sperber, K. 2001. Regulation of class II expression in monocytic cells after HIV-1 infection. Journal of Immunology, 167: 2331–2342.Google Scholar
  147. Rappocciolo, G., Birch, J. & Ellis, S.A. 2003. Down-regulation of MHC class I expression by equine herpesvirus-1. Journal of General Virology, 84: 293–300.CrossRefPubMedGoogle Scholar
  148. Reading, P.C., Khanna, A. & Smith, G.L. 2002. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology, 292: 285–298.CrossRefPubMedGoogle Scholar
  149. Reusch, U., Muranyi, W., Lucin, P., Burgert, H.G., Hengel, H. & Koszinowski, U.H. 199. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO Journal, 18: 1081–1091.Google Scholar
  150. Reyburn, H.T., Mandelboim, O., Vales Gomez, M., Davis, D.M., Pazmany, L. & Strominger, J.L. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature, 386: 514–517.CrossRefPubMedGoogle Scholar
  151. Rode, H.J., Janssen, W., Rosenwolff, A., Bugert, J.J., Thein, P., Becker, Y. & Darai, G. 1993. The genome of equine herpesvirus type-2 harbors an interleukin-10 (IL10)-like gene. Virus Genes, 7: 111–116.CrossRefPubMedGoogle Scholar
  152. Rosengard, A.M., Liu, Y., Nie, Z.P. & Jimenez, R. 2002. Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement. Proceedings of the National Academy of Sciences, USA, 99: 8808–8813.Google Scholar
  153. Rother, R.P., Rollins, S.A., Fodor, W.L., Albrecht, J.C., Setter, E., Fleckenstein, B. & Squinto, S.P. 1994. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus Saimiri. Journal of Virology, 68: 730–737.PubMedGoogle Scholar
  154. Saederup, N., Aguirre, S.A., Sparer, T.E., Bouley, D.M. & Mocarski, E.S. 2001. Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. Journal of Virology, 75: 9966–9976.CrossRefPubMedGoogle Scholar
  155. Saederup, N., Lin, Y.C., Dairaghi, D.J., Schall, T.J. & Mocarski, E.S. 1999. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proceedings of the National Academy of Sciences, USA, 96: 10881–10886.CrossRefGoogle Scholar
  156. Saifuddin, M., Parker, C.J., Peeples, M.E., Gorny, M.K., Zollapazner, S., Ghassemi, M., Rooney, I.A., Atkinson, J.P. & Spear, G.T. 1995. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-L. Journal of Experimental Medicine, 182: 501–509.CrossRefPubMedGoogle Scholar
  157. Saraiva, M. & Alcami, A. 2001. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. Journal of Virology, 75: 226–233.CrossRefPubMedGoogle Scholar
  158. Saraiva, M., Smith, P., Fallon, P.G. & Alcami, A. 2002. Inhibition of type 1 cytokinemediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. Journal of Experimental Medicine, 196: 829–839.CrossRefPubMedGoogle Scholar
  159. Sarid, R., Sato, T., Bohenzky, R.A., Russo, J.J. & Chang, Y. 1997. Kaposi’s sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nature Medicine, 3: 293–298.CrossRefPubMedGoogle Scholar
  160. Schindler, M., Wurfl, S., Benaroch, P., Greenough, T.C., Daniels, R., Easterbrook, P., Brenner, M., Munch, J. & Kirchhoff, F. 2003. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. Journal of Virology, 77: 10548–10556.CrossRefPubMedGoogle Scholar
  161. Schust, D.J., Tortorella, D., Seebach, J., Phan, C. & Ploegh, H.L. 1998. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation of the human cytomegalovirus (HCMV) gene products US2 and US11. Journal of Experimental Medicine, 188: 497–503. [See also correction: ibid., 188: 497.]CrossRefPubMedGoogle Scholar
  162. Senkevich, T.G. & Moss, B. 1998. Domain structure, intracellular trafficking, and beta 2-microglobulin binding of a major histocompatibility complex class I homolog encoded by molluscum contagiosum virus. Virology, 250: 397–407.CrossRefPubMedGoogle Scholar
  163. Shisler, J., Yang, C., Walter, B., Ware, C.F. & Gooding, L.R. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to fas-induced apoptosis. Journal of Virology, 71: 8299–8306.PubMedGoogle Scholar
  164. Shisler, J.L. & Moss, B. 2001. Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology, 282: 14–25.CrossRefPubMedGoogle Scholar
  165. Skaletskaya, A., Bartle, L.M., Chittenden, T., McCormick, A.L., Mocarski, E.S. & Goldmacher, V.S. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proceedings of the National Academy of Sciences, USA, 98: 7829–7834.CrossRefGoogle Scholar
  166. Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckman, M.P., Jerzy, R., Dower, S.K., Cosman, D. & Goodwin, R.G. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248: 1019–1023.PubMedGoogle Scholar
  167. Smith, C.A., Davis, T., Wignall, J.M., Din, W.S., Farrah, T., Upton, C., McFadden, G. & Goodwin, R.G. 1991. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochemical and Biophysical Research Communications, 176: 335–342.CrossRefPubMedGoogle Scholar
  168. Smith, C.A., Hu, F.Q., Smith, T.D., Richards, C.L., Smolak, P., Goodwin, R.G. & Pickup, D.J. 1996. Cowpox virus encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB,that binds TNF but not LT alpha. Virology, 223: 132–147.CrossRefPubMedGoogle Scholar
  169. Smith, C.A., Smith, T.D., Smolak, P.J., Friend, D., Hagen, H., Gerhart, M., Park, L., Pickup, D.J., Torrance, D., Mohler, K., Scooley, K. & Goodwin, R.G. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology, 236: 316–327.CrossRefPubMedGoogle Scholar
  170. Smith, H.R., Idris, A.H. & Yokoyama, W.M. 2001. Murine natural killer cell activation/receptors. Immunological Reviews, 181: 115–125.CrossRefPubMedGoogle Scholar
  171. Smith, V.P., Bryant, N.A. & Alcami, A. 2000. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. Journal of General Virology, 81: 1223–1230.PubMedGoogle Scholar
  172. Spear, G.T., Lurain, N.S., Parker, C.J., Ghassemi, M., Payne, G.H. & Saifuddin, M. 1995. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of 2 unrelated enveloped viruses — human T-cell leukemia/lymphoma virus type-I (HTLV-I) and human cytomegalovirus (HCMV). Journal of Immunology, 155: 4376–4381.Google Scholar
  173. Spiller, O.B., Morgan, B.P., Tufaro, F. & Devine, D.V. 1996. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. European Journal of Immunology, 26: 1532–1538.PubMedGoogle Scholar
  174. Stine, J.T., Wood, C., Hill, M., Epp, A., Raport, C.J., Schweickart, V.L., Endo, Y., Sasaki, T., Simmons, G., Boshoff, C., Clapham, P., Chang, Y., Moore, P., Gray, P.W. & Chantry, D. 2000. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis,and selectively chemoattracts TH2 cells. Blood, 95: 1151–1157.PubMedGoogle Scholar
  175. Strockbine, L.D., Cohen, J.L., Farrah, T., Lyman, S.D., Wagener, F., DuBose, R.F., Armitage, R.J. & Spriggs, M.K. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. Journal of Virology, 72: 4015–4021.PubMedGoogle Scholar
  176. Stumptner-Cuvelette, P., Morchoisne, S., Dugast, M., Le Gall, S., Raposo, G., Schwartz, O. & Benaroch, P. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proceedings of the National Academy of Sciences, USA, 98: 12144–12149.CrossRefGoogle Scholar
  177. Sturzl, M., Hohenadl, C., Zietz, C., Castanos-Velez, E., Wunderlich, A., Ascherl, G., Biberfeld, P., Monini, P., Browning, P.J. & Ensoli, B. 1999. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Karposi’s sarcoma spindle cells. Journal of the National Cancer Institute, 91: 1725–1733.CrossRefPubMedGoogle Scholar
  178. Sundararajan, R. & White, E. 2001. E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. Journal of Virology, 75: 7506–7516.CrossRefPubMedGoogle Scholar
  179. Sutherland, C.L., Chalupny, N.J. & Cosman, D. 2001. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunological Reviews, 181: 185–192.CrossRefPubMedGoogle Scholar
  180. Swigut, T., Iafrate, A.J., Muench, J., Kirchhoff, F. & Skowronski, J. 2000. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression. Journal of Virology, 74: 5691–5701.CrossRefPubMedGoogle Scholar
  181. Teodoro, J.G. & Branton, P.E. 1997. Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kiloDalton E1B protein of human adenovirus type 5. Journal of Virology, 71: 3620–3627.PubMedGoogle Scholar
  182. Tewari, M. & Dixit, V.M. 1995. Fas-induced and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus CrmA gene-product. Journal of Biological Chemistry, 270: 3255–3260.CrossRefPubMedGoogle Scholar
  183. Thale, R., Lucin, P., Schneider, K., Eggers, M. & Koszinowski, U.H. 1994. Identification and expression of a murine cytomegalovirus early gene coding for an FC receptor. Journal of Virology, 68: 7757–7765.PubMedGoogle Scholar
  184. Thomas, M. & Banks, L. 1998. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene, 17: 2943–2954.CrossRefPubMedGoogle Scholar
  185. Thomas, M. & Banks, L. 1999. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. Journal of General Virology, 80: 1513–1517.PubMedGoogle Scholar
  186. Tidona, C.A. & Darai, G. 1997. The complete DNA sequence of lymphocystis disease virus. Virology, 230: 207–216.CrossRefPubMedGoogle Scholar
  187. Tomasec, P., Braud, V.M., Rickards, C., Powell, M.B., McSharry, B.P., Gaddola, S., Cerundolo, V., Borysiewicz, L.K., McMicheal, A.J. & Wilkinson, G.W.G. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science, 287: 1031–1033.CrossRefPubMedGoogle Scholar
  188. Tomazin, R., Boname, J., Hegde, N.R., Lewinsohn, D.H., Altschuler, Y., Jones, T.R., Cresswell, P., Nelson, J.A.. Riddell, S.R., & Johnson, D.C. 1999. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4(+) T cells. Nature Medicine, 5: 1039–1043.PubMedGoogle Scholar
  189. Tong, X., Boll, W., Kirchhausen, T. & Howley, P.M. 1998. Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. Journal of Virology, 72: 476–482.PubMedGoogle Scholar
  190. Tortorella, D., Gewurz, B.E., Furman, M.H., Schust, D.J. & Pleogh, H.L. 2000. Viral subversion of the immune system. Annual Review of Immunology, 18: 861–926.CrossRefPubMedGoogle Scholar
  191. Tripp, R.A., Jones, L.P., Haynes, L.M., Zheng, H.Q., Murphy, P.M. & Anderson, L.J. 2001. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nature Immunology, 2: 732–738.CrossRefPubMedGoogle Scholar
  192. Tseng, C.T. & Klimpel, G.R. 2002. Binding of hepatitis C envelope protein E2 to CD81 inhibits natural killer cell functions. Journal of Experimental Medicine, 195: 43–49.PubMedCrossRefGoogle Scholar
  193. Tsukahara, T., Kannagi, M., Ohashi, T., Kato, H., Arai, M., Nunez, G., Iwanaga, Y., Yamamoto, N., Ohtani, K., Nakamura, M. & Fujii, M. 1999. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 tax through NF-kappa B in apoptosis-resistant T-cell transfectants with tax. Journal of Virology, 73: 7981–7987.PubMedGoogle Scholar
  194. Tulman, E.R., Alfonso, C.L., Lu, Z., Zsak, L., Kutish, G.F. & Rock, D.L. 2001. Genome of lumpy skin disease virus. Journal of Virology, 75: 7122–7130.CrossRefPubMedGoogle Scholar
  195. Turner, S.J., Silke, J., Kenshole, B. & Ruby, J. 2000. Characterization of the ectromelia virus serpin SPI-2. Journal of General Virology, 81: 2425–2430.PubMedGoogle Scholar
  196. Twardzik, D.R., Brown, J.P., Ranchalis, J.E., Todaro, G.J. & Moss, B. 1985. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proceedings of the National Academy of Sciences, USA, 82: 5300–5304.Google Scholar
  197. Upton, C., Mossman, K. & McFadden, G. 1992. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science, 258: 1369–1372.PubMedGoogle Scholar
  198. Vanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R.B. & Smith, G.L. 1998. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proceedings of the National Academy of Sciences, USA, 95: 7544–7549.CrossRefGoogle Scholar
  199. Wang, E.C.Y., McSharry, B., Retiere, C., Tomasec, P., Williams, S., Borysiewicz, L.K., Braud, V.M. & Wilkinson, G.W.G. 2002. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proceedings of the National Academy of Sciences, USA, 99: 7570–7575.Google Scholar
  200. Wang, G.H., Bertin, J., Wang, Y., Martin, D.A., Wang, J., Tomaselli, K.J., Armstrong, R.C. & Cohen, J.I. 1997. Bovine herpesvirus 4 BORFE-2 protein inhibits fas-and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses. Journal of Virology, 71: 8928–8932.PubMedGoogle Scholar
  201. Wang, G.H., Garvey, T.L. & Cohen, J.I. 1999. The murine gammaherpesvirus-68 M11 protein inhibits Fas-and TNF-induced apoptosis. Journal of General Virology, 80: 2737–2740.PubMedGoogle Scholar
  202. Wang, X.W., Gibson, M.K., Vermeulen, W., Yeh, H., Forrester, K., Sturzbecher, H.W., Hoiejmakers, J.H.J. & Harris, C.C. 1995. Abrogation of P53-induced apoptosis by the hepatitis-B virus-X gene. Cancer Research, 55: 6012–6016.PubMedGoogle Scholar
  203. Watkins, J.F. 1964. Adsorption of sensitized sheep erythrocytes to HeLa cells infected with herpes simplex virus. Nature, 202: 1364–1365.PubMedGoogle Scholar
  204. Wiertz, E.J.H.J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T.R., Rapoport, T.A. & Ploegh, H.L. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature, 384: 432–438.CrossRefPubMedGoogle Scholar
  205. Wolf, D., Witte, V., Laffert, B., Blume, K., Stromer, E., Trapp, S., D’Aloja, P., Schurmann, A. & Baur, A.S. 2001. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nature Medicine, 7: 1217–1224.CrossRefPubMedGoogle Scholar
  206. Xiang, Y. & Moss, B. 1999. Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the molluscum contagiosum poxvirus. Virology, 257: 297–302.CrossRefPubMedGoogle Scholar
  207. Xiang, Y. & Moss, B. 1999. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proceedings of the National Academy of Sciences, USA, 96: 11537–11542. [See also correction: ibid., 97:11673.]CrossRefGoogle Scholar
  208. Xu, X.M., Nash, P. & McFadden, G. 2000. Myxoma virus expresses a TNF receptor homolog with two distinct functions. Virus Genes, 21: 97–109.CrossRefPubMedGoogle Scholar
  209. Yao, Z.B., Fanslow, W.C., Seldin, M.F., Rousseau, A.M., Painter, S.L., Comeau, M.R., Cohen, J.I. & Spriggs, M.K. 1995. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity, 3: 811–821.CrossRefPubMedGoogle Scholar
  210. Yewdell, J.W. & Hill, A.B. 2002. Viral interference with antigen presentation. Nature Immunology, 3: 1019–1025.CrossRefPubMedGoogle Scholar
  211. Yin, Y., Maoury, B. & Fahraeus, R. 2003. Self-inhibition of synthesis and antigen presentation by Epstein-Barr-virus encoded EBNA1. Science, 301: 1371–1374.CrossRefPubMedGoogle Scholar
  212. York, I.A. & Johnson, D.C. 1993. Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. Journal of Infectious Diseases, 168: 1127–1132.PubMedGoogle Scholar
  213. Zheng, Z.Y. & Zucker-Franklin, D. 1992. Apparent effectiveness of natural killer cells vis-à-vis retrovirus-infected targets. Journal of Immunology, 148: 3679–3685.Google Scholar
  214. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V.M. & Salvesen, G.S. 1997. Target protease specificity of the viral serpin CrmA — Analysis of five caspases. Journal of Biological Chemistry, 272: 7797–7800.PubMedGoogle Scholar
  215. Ziegler, H., Thale, R., Lucin, P., Muranyi, W., Flohr, T., Hengel, H., Farrell, H., Rawlinson, W. & Koszinowski, U.H. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartment. Immunity, 6: 57–66.CrossRefPubMedGoogle Scholar
  216. Zocchi, M.R., Rubartelli, A., Morgavi, P. & Poggi, A. 1998. HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels. Journal of Immunology, 161: 2938–2943.Google Scholar
  217. Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y. & Yamanishi, K. 1999. Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. Journal of Virology, 73: 5926–5933.PubMedGoogle Scholar

Copyright information

© IAEA 2005

Authors and Affiliations

  • Laurent Gillet
    • 1
  • Alain Vanderplasschen
    • 1
  1. 1.Immunology-Vaccinology (B43b), Department of Infectious and Parasitic Diseases, Faculty of Veterinary MedicineUniversity of LiègeLiègeBelgium

Personalised recommendations